Twinbeech Capital LP Amphastar Pharmaceuticals, Inc. Transaction History
Twinbeech Capital LP
- $4.95 Billion
- Q1 2025
A detailed history of Twinbeech Capital LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 43,986 shares of AMPH stock, worth $1.12 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
43,986
Previous 46,797
6.01%
Holding current value
$1.12 Million
Previous $1.74 Million
26.6%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$152 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.9 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$56.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.6 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.25B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...